RT Journal
A1 Spain DA
T1 Statins for everyone: Are we there yet?: comment on “effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay”
JF Archives of Surgery
JO Archives of Surgery
YR 2012
FD February 1
VO 147
IS 2
SP 189
OP 189
DO 10.1001/archsurg.2011.1014
UL http://dx.doi.org/10.1001/archsurg.2011.1014
AB 
Chopra et al1 examined the effects of the lipid-lowering 3-hydroxy-3-methylglutaryl–coenzyme A reductase inhibitors (“statins”) on postoperative complications in patients who were naive to these medications. They performed a rigorous systematic review and meta-analysis of 15 studies with almost 2300 patients. The major findings were (1) 44% risk reduction for atrial fibrillation, with a number needed to treat of 6; (2) 47% risk reduction for myocardial infarction, with a number needed to treat of 23; and (3) a 32% reduction in hospital length of stay.